Paola Ranalli Selected Research

Aspirin (Acetylsalicylic Acid)

1/2022	Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia.
1/2020	A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia.
1/2018	The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paola Ranalli Research Topics

Disease

4	Essential Thrombocythemia 01/2022 - 01/2018
2	Thrombocytopenia (Thrombopenia) 01/2021 - 01/2021
2	Neoplasms (Cancer) 03/2020 - 02/2016
2	Polycythemia Vera 03/2020 - 01/2018
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021
1	Splenomegaly 01/2021
1	Disease Susceptibility (Diathesis) 03/2020
1	von Willebrand Diseases (von Willebrand's Disease) 02/2016
1	Hemophilia A (Haemophilia) 02/2016

Drug/Important Bio-Agent (IBA)

3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2018
1	ThromboxanesIBA 01/2022
1	GlucosidasesIBA 01/2021
1	VaccinesIBA 01/2021
1	von Willebrand FactorIBA 03/2020
1	Biomarkers (Surrogate Marker)IBA 03/2020
1	Thromboxane B2IBA 01/2018
1	Factor VIII (Coagulation Factor VIII)IBA 02/2016
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 02/2016
1	Biological ProductsIBA 02/2016

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2020
1	Operative Surgical Procedures 02/2016